276 related articles for article (PubMed ID: 21564435)
1. Clinical perspective: iron replacement therapy in chronic heart failure.
Cowie MR; Lucas R
Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435
[No Abstract] [Full Text] [Related]
2. Use of intravenous iron supplementation in chronic kidney disease: an update.
Macdougall IC; Geisser P
Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
[TBL] [Abstract][Full Text] [Related]
3. Clinical update: intravenous iron for anaemia.
Auerbach M; Ballard H; Glaspy J
Lancet; 2007 May; 369(9572):1502-1504. PubMed ID: 17482969
[No Abstract] [Full Text] [Related]
4. IV iron in heart failure: theoretical concerns need clinical confirmation.
Cowie MR; Lucas R
Int J Clin Pract; 2011 Sep; 65(9):1014-5. PubMed ID: 21849013
[No Abstract] [Full Text] [Related]
5. Ferric carboxymaltose in patients with heart failure and iron deficiency.
Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
[TBL] [Abstract][Full Text] [Related]
6. A Meta-analysis of Intravenous Iron Therapy for Patients With Iron Deficiency and Heart Failure.
Osman M; Syed M; Balla S; Kheiri B; Faisaluddin M; Bianco C
Am J Cardiol; 2021 Feb; 141():152-153. PubMed ID: 33259800
[No Abstract] [Full Text] [Related]
7. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
[TBL] [Abstract][Full Text] [Related]
8. Intravenous Iron Use in the Care of Patients with Kidney Disease.
Macdougall IC
Clin J Am Soc Nephrol; 2019 Oct; 14(10):1528-1530. PubMed ID: 31175103
[No Abstract] [Full Text] [Related]
9. Should intravenous iron be upfront therapy for iron deficiency anemia?
Auerbach M
Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
[No Abstract] [Full Text] [Related]
10. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
12. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.
Miñana G; Cardells I; Palau P; Llàcer P; Fácila L; Almenar L; López-Lereu MP; Monmeneu JV; Amiguet M; González J; Serrano A; Montagud V; López-Vilella R; Valero E; García-Blas S; Bodí V; de la Espriella-Juan R; Sanchis J; Chorro FJ; Bayés-Genís A; Núñez J;
Clin Cardiol; 2018 Jun; 41(6):729-735. PubMed ID: 29607528
[TBL] [Abstract][Full Text] [Related]
13. [Parenteral iron replacement].
Cynke E
Praxis (Bern 1994); 1997 May; 86(20):835-6. PubMed ID: 9312810
[No Abstract] [Full Text] [Related]
14. [Is there an indication for intravenous iron replacement in, for example, by autologous blood donation-induced iron deficiency and is there a theoretically possible indication for intravenous administration for the not approved Ferrum Hausmann preparation?].
Kruse HJ; Creutzig A
Internist (Berl); 1996 Oct; 37(10):1059. PubMed ID: 9019452
[No Abstract] [Full Text] [Related]
15. Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction.
Robles-Mezcua A; González-Cruces N; Ruiz-Salas A; Morcillo-Hidalgo L; Robledo-Carmona J; Gómez-Doblas JJ; de Teresa E; García-Pinilla JM
Int J Cardiol; 2016 Jan; 202():118-20. PubMed ID: 26397399
[No Abstract] [Full Text] [Related]
16. Update on intravenous iron choices.
Larson DS; Coyne DW
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):186-91. PubMed ID: 24401789
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Onken JE; Bregman DB; Harrington RA; Morris D; Acs P; Akright B; Barish C; Bhaskar BS; Smith-Nguyen GN; Butcher A; Koch TA; Goodnough LT
Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
[TBL] [Abstract][Full Text] [Related]
18. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial.
Seid MH; Derman RJ; Baker JB; Banach W; Goldberg C; Rogers R
Am J Obstet Gynecol; 2008 Oct; 199(4):435.e1-7. PubMed ID: 18928998
[TBL] [Abstract][Full Text] [Related]
19. Anemia and iron deficiency--new therapeutic targets in heart failure?
Dec GW
N Engl J Med; 2009 Dec; 361(25):2475-7. PubMed ID: 19920053
[No Abstract] [Full Text] [Related]
20. Review of available intravenous iron preparations in hemodialysis.
Palmer K; Cameron K; Battistella M
CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
